Noetik Raises $40 Million to Advance Precision Cancer Therapeutics Tech Platform nextdigitalhealth.com

Noetik, a California-based biotech startup that leverages artificial intelligence and machine learning to develop next-generation cancer treatments, has secured $40 million in an oversubscribed series A funding round to expand its spatial omics-based cancer therapeutics platform.

Co-founded by Ronald Alfa and Jacob Rinaldi, the startup aims to combine the power of artificial intelligence and deep patient data to develop innovative cancer therapeutics, solving the challenges that exist in the development of new cancer therapies.